Home
HelpTest Code HIVCO HIV-1/2 Antibodies and HIV-1 p24 Antigen (4th Generation)
Additional Codes
| Software | Test Code |
|---|---|
| Label Text | HIVCO |
| EPIC | LAB11153 |
Performing Laboratory
NorDx Laboratories
Useful For
Simultaneous qualitative screening and detection of antibodies to Human Immunodeficiency Virus (HIV), Type 1 (HIV-1 group M and group O) and/or Type 2, and of HIV p24 antigen.
Reactive (positive) specimens will reflex for supplemental differentiation testing.
Method Name
Chemiluminescent Microparticle Immunoassay (CMIA)
Reference Values
Negative (reported as negative or positive)
Days and Times Test Performed
Monday through Friday
Report Available
1 Day
if Negative
Specimen Type
Serum
Preferred Container
Serum Separator Tube (SST)
Preferred Volume
Serum: 2 mL (Serum Separator Tube (SST))
Minimum Volume
Serum: 1.5 mL (Serum Separator Tube (SST))
Specimen Collection and Handling
Spin specimen, separate from clot and send refrigerated.
Specimen Stability Information
Specimen Type: Serum
Frozen: 3 Months
Refrigerated: 7 Days
Must be spun/separated within: 2 Hours
Add On Capable
Yes
Advance Beneficiary Notice Requirements
This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policies. Please verify that the diagnosis code (ICD code) you have chosen demonstrates medical necessity for the test as documented in the physician’s patient record. The CMS web site is available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD code chosen.
CPT Code Information
|
CPT Code |
CPT Description |
CPT Disclaimer |
|---|---|---|
| 86701 | HIV-1 | if Indicated |
| 86702 | HIV-2 | if Indicated |
| 87389 | Infectious Agent Antigen Detection by Immunoassay Technique, Qualitative or Semiquantitative, Multiple-Step Method, HIV-1 Antigen(s), with HIV-1 and HIV-2 Antibodies, Single Result |
Keywords
HIV (HUMAN IMMUNODEFICIENCY VIRUS)
HIV 1 AND 2 ANTIBODY
HIV ANTIBODY (HIV-1, HIV-2)
HIV P24 ANTIGEN
HUMAN IMMUNODIFICIENCY VIRUS (HIV) ANTIBODIES
Performing Laboratory Location
NorDx Laboratories
LOINC Code Information
56888-1
Clinical Significance
Assay performance characteristics have not been established for individuals younger than 2 years of age. False positives may occur in children less than 18 months of age due to passively acquired maternal antibody. Follow up testing with HIV RNA QN PCR (HIVVL) is recommended.
Acceptable Alternative Container(s)
Red Top Tube
Rejection Information
The following specimens will not be tested:
1. Heat-inactivated specimens
2. Cloudy specimens
3. Grossly lipemic specimens
4. Hemolyzed specimens
5. Obvious microbial contamination
6. Specimens containing particulate matter